130 related articles for article (PubMed ID: 28785244)
1. AM-37 and ST-36 Are Small Molecule Bombesin Receptor Antagonists.
Moody TW; Tashakkori N; Mantey SA; Moreno P; Ramos-Alvarez I; Leopoldo M; Jensen RT
Front Endocrinol (Lausanne); 2017; 8():176. PubMed ID: 28785244
[TBL] [Abstract][Full Text] [Related]
2. ML-18 is a non-peptide bombesin receptor subtype-3 antagonist which inhibits lung cancer growth.
Moody TW; Mantey SA; Moreno P; Nakamura T; Lacivita E; Leopoldo M; Jensen RT
Peptides; 2015 Feb; 64():55-61. PubMed ID: 25554218
[TBL] [Abstract][Full Text] [Related]
3. Bombesin receptor subtype-3 agonists stimulate the growth of lung cancer cells and increase EGF receptor tyrosine phosphorylation.
Moody TW; Sancho V; di Florio A; Nuche-Berenguer B; Mantey S; Jensen RT
Peptides; 2011 Aug; 32(8):1677-84. PubMed ID: 21712056
[TBL] [Abstract][Full Text] [Related]
4. Bombesin marine toxin conjugates inhibit the growth of lung cancer cells.
Moody TW; Pradhan T; Mantey SA; Jensen RT; Dyba M; Moody D; Tarasova NI; Michejda CJ
Life Sci; 2008 Apr; 82(15-16):855-61. PubMed ID: 18336841
[TBL] [Abstract][Full Text] [Related]
5. A possible new target in lung-cancer cells: The orphan receptor, bombesin receptor subtype-3.
Moreno P; Mantey SA; Lee SH; Ramos-Álvarez I; Moody TW; Jensen RT
Peptides; 2018 Mar; 101():213-226. PubMed ID: 29410320
[TBL] [Abstract][Full Text] [Related]
6. Identification of key amino acids in the gastrin-releasing peptide receptor (GRPR) responsible for high affinity binding of gastrin-releasing peptide (GRP).
Nakagawa T; Hocart SJ; Schumann M; Tapia JA; Mantey SA; Coy DH; Tokita K; Katsuno T; Jensen RT
Biochem Pharmacol; 2005 Feb; 69(4):579-93. PubMed ID: 15670577
[TBL] [Abstract][Full Text] [Related]
7. Expression of mRNA for three bombesin receptor subtypes in human bronchial epithelial cells.
DeMichele MA; Davis AL; Hunt JD; Landreneau RJ; Siegfried JM
Am J Respir Cell Mol Biol; 1994 Jul; 11(1):66-74. PubMed ID: 8018339
[TBL] [Abstract][Full Text] [Related]
8. Discovery of high affinity bombesin receptor subtype 3 agonists.
Wu JM; Nitecki DE; Biancalana S; Feldman RI
Mol Pharmacol; 1996 Nov; 50(5):1355-63. PubMed ID: 8913368
[TBL] [Abstract][Full Text] [Related]
9. Biology and pharmacology of bombesin receptor subtype-3.
Majumdar ID; Weber HC
Curr Opin Endocrinol Diabetes Obes; 2012 Feb; 19(1):3-7. PubMed ID: 22157398
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the bound conformation of bombesin to the BB1 and BB2 receptors.
Vila-Julià G; Rubio-Martinez J; Perez JJ
Int J Biol Macromol; 2024 Jan; 255():127843. PubMed ID: 37956803
[TBL] [Abstract][Full Text] [Related]
11. Evidence for autocrine actions of neuromedin B and gastrin-releasing peptide in non-small cell lung cancer.
Siegfried JM; Krishnamachary N; Gaither Davis A; Gubish C; Hunt JD; Shriver SP
Pulm Pharmacol Ther; 1999; 12(5):291-302. PubMed ID: 10545285
[TBL] [Abstract][Full Text] [Related]
12. Systematic optimization of a lead-structure identities for a selective short peptide agonist for the human orphan receptor BRS-3.
Weber D; Berger C; Heinrich T; Eickelmann P; Antel J; Kessler H
J Pept Sci; 2002 Aug; 8(8):461-75. PubMed ID: 12212809
[TBL] [Abstract][Full Text] [Related]
13. Expression of mRNA for gastrin-releasing peptide receptor by human bronchial epithelial cells. Association with prolonged tobacco exposure and responsiveness to bombesin-like peptides.
Siegfried JM; DeMichele MA; Hunt JD; Davis AG; Vohra KP; Pilewski JM
Am J Respir Crit Care Med; 1997 Aug; 156(2 Pt 1):358-66. PubMed ID: 9279210
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of growth of human malignant glioblastoma in nude mice by antagonists of bombesin/gastrin-releasing peptide.
Kiaris H; Schally AV; Sun B; Armatis P; Groot K
Oncogene; 1999 Nov; 18(50):7168-73. PubMed ID: 10597318
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of proliferation and migration of a colorectal cancer cell line by amidated and glycine-extended gastrin-releasing peptide via the same receptor.
Patel O; Dumesny C; Giraud AS; Baldwin GS; Shulkes A
Biochem Pharmacol; 2004 Dec; 68(11):2129-42. PubMed ID: 15498503
[TBL] [Abstract][Full Text] [Related]
16. Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells.
Frucht H; Gazdar AF; Park JA; Oie H; Jensen RT
Cancer Res; 1992 Mar; 52(5):1114-22. PubMed ID: 1310640
[TBL] [Abstract][Full Text] [Related]
17. Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes.
Lin JT; Coy DH; Mantey SA; Jensen RT
J Pharmacol Exp Ther; 1995 Oct; 275(1):285-95. PubMed ID: 7562561
[TBL] [Abstract][Full Text] [Related]
18. Non-peptide bombesin receptor antagonists, kuwanon G and H, isolated from mulberry.
Mihara S; Hara M; Nakamura M; Sakurawi K; Tokura K; Fujimoto M; Fukai T; Nomura T
Biochem Biophys Res Commun; 1995 Aug; 213(2):594-9. PubMed ID: 7646517
[TBL] [Abstract][Full Text] [Related]
19. Systematic development of bombesin/gastrin-releasing peptide antagonists.
Coy DH; Jensen RT; Jiang NY; Lin JT; Bogden AE; Moreau JP
J Natl Cancer Inst Monogr; 1992; (13):133-9. PubMed ID: 1389686
[TBL] [Abstract][Full Text] [Related]
20. Appetite-modifying effects of bombesin receptor subtype-3 agonists.
Majumdar ID; Weber HC
Handb Exp Pharmacol; 2012; (209):405-32. PubMed ID: 22249826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
